Related Experiment Videos
Aortic atheromatosis and risks of cerebral embolization
Insights
Mobile aortic atheroma is a significant risk factor for stroke and neurologic complications during heart surgery. Further research is needed to understand emboli composition and establish prevention strategies.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Surgical Innovation
Background:
- Transesophageal echocardiography has identified aortic atheromatosis as a key source of cerebral embolization.
- Mobile atheromatous plaque in the aorta is a significant risk factor for stroke.
- Aortic plaque is a major contributor to neurologic complications in patients undergoing coronary bypass surgery.
Purpose of the Study:
- To highlight the role of aortic atheromatosis in cerebral embolization.
- To investigate the impact of aortic plaque on perioperative neurologic outcomes.
- To explore potential prevention strategies for embolization during cardiac surgery.
Main Methods:
- Utilizing transesophageal echocardiography to identify and assess aortic atheromatous plaque.
- Observing intraoperative emboli during coronary bypass surgery.
- Analyzing the composition of emboli, with a focus on atheromatous material.
Main Results:
- Mobile atheromatous plaque in the ascending aorta and aortic arch is an independent risk factor for stroke.
- Aortic plaque is the primary cause of perioperative neurologic morbidity in coronary bypass surgery.
- Emboli, potentially including atheromatous material, are observed during cardiac surgery, particularly upon aortic clamp release.
Conclusions:
- Aortic atheromatosis is a critical factor in perioperative neurologic complications and stroke.
- Surgical techniques may need modification to prevent embolization from mobile aortic atheroma.
- Further studies on the natural history of aortic atheroma are required for effective secondary prevention strategies.
Abstract:
With the advent of transesophageal echocardiography, aortic atheromatosis has emerged as an important source of cerebral embolization. Mobile atheromatous plaque in the ascending aorta and aortic arch has been shown to constitute a strong and independent risk factor in patients with stroke. In patients undergoing coronary bypass surgery, it is the single most important contributing factor to perioperative neurologic morbidity. Emboli originating in the heart, aorta, and proximal cerebral vasculature have been observed intraoperatively in patients undergoing coronary bypass surgery, especially when aortic clamps are released. The constitution of these emboli is unclear, although an indeterminate fraction undoubtedly represents dislodged atheromatous material. The impact of such embolization in terms of neurologic outcome is currently under investigation. Prevention of embolization from mobile aortic atheroma in patients undergoing cardiac surgery may require modification of surgical technique. Secondary prevention in patients with a history of embolization can only be determined once the natural history of such lesions is established.